Literature DB >> 20722001

Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis.

Tzu-Hsuan Yeh1, Lindsay Krauland, Vijay Singh, Baobo Zou, Prathab Devaraj, Donna B Stolz, Jonathan Franks, Satdarshan P S Monga, Eizaburo Sasatomi, Jaideep Behari.   

Abstract

UNLABELLED: Beta-catenin plays important roles in liver physiology and hepatocarcinogenesis. While studying the role of β-catenin in diet-induced steatohepatitis, we recently found that liver-specific β-catenin knockout (KO) mice exhibit intrahepatic cholestasis. This study was undertaken to further characterize the role of β-catenin in biliary physiology. KO mice and wild-type (WT) littermates were fed standard chow or a diet supplemented with 0.5% cholic acid for 2 weeks. Chow-fed KO mice had higher serum and hepatic total bile acid levels and lower bile flow rate than WT mice. Expression levels of bile acid biosynthetic genes were lower and levels of major bile acid exporters were similar, which therefore could not explain the KO phenotype. Despite loss of the tight junction protein claudin-2, KO mice had preserved functional integrity of tight junctions. KO mice had bile canalicular morphologic abnormalities as evidenced by staining for F-actin and zona occludens 1. Electron microscopy revealed dilated and tortuous bile canaliculi in KO livers along with decreased canalicular and sinusoidal microvilli. KO mice on a cholic acid diet had higher hepatic and serum bile acid levels, bile ductular reaction, increased pericellular fibrosis, and dilated, misshapen bile canaliculi. Compensatory changes in expression levels of several bile acid transporters and regulatory genes were found in KO livers.
CONCLUSION: Liver-specific loss of β-catenin leads to defective bile canalicular morphology, bile secretory defect, and intrahepatic cholestasis. Thus, our results establish a critical role for β-catenin in biliary physiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722001      PMCID: PMC2947599          DOI: 10.1002/hep.23801

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  29 in total

Review 1.  Regulation of the blood-biliary barrier: interaction between gap and tight junctions in hepatocytes.

Authors:  Takashi Kojima; Toshinobu Yamamoto; Masaki Murata; Hideki Chiba; Yasuo Kokai; Norimasa Sawada
Journal:  Med Electron Microsc       Date:  2003-09

2.  Senescence marker protein-30 (SMP30) induces formation of microvilli and bile canaliculi in Hep G2 cells.

Authors:  Akihito Ishigami; Toshiko Fujita; Haruhiko Inoue; Setsuko Handa; Sachiho Kubo; Yoshitaka Kondo; Naoki Maruyama
Journal:  Cell Tissue Res       Date:  2005-02-16       Impact factor: 5.249

3.  Dilated bile canaliculi and attenuated decrease of nerve-dependent bile secretion in connexin32-deficient mouse liver.

Authors:  A Temme; F Stümpel; G Söhl; E P Rieber; K Jungermann; K Willecke; T Ott
Journal:  Pflugers Arch       Date:  2001-09       Impact factor: 3.657

4.  beta-Catenin and met deregulation in childhood Hepatoblastomas.

Authors:  Sarangarajan Ranganathan; Xinping Tan; Satdarshan P S Monga
Journal:  Pediatr Dev Pathol       Date:  2005-10-05

Review 5.  Bile salt transporters: molecular characterization, function, and regulation.

Authors:  Michael Trauner; James L Boyer
Journal:  Physiol Rev       Date:  2003-04       Impact factor: 37.312

6.  Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.

Authors:  S Colnot; T Decaens; M Niwa-Kawakita; C Godard; G Hamard; A Kahn; M Giovannini; C Perret
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

7.  Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration.

Authors:  Wendong Huang; Ke Ma; Jun Zhang; Mohammed Qatanani; James Cuvillier; Jun Liu; Bingning Dong; Xiongfei Huang; David D Moore
Journal:  Science       Date:  2006-04-14       Impact factor: 47.728

8.  Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.

Authors:  Bernard J Komoroski; Shimin Zhang; Hongbo Cai; J Matthew Hutzler; Reginald Frye; Timothy S Tracy; Stephen C Strom; Thomas Lehmann; Catharina Y W Ang; Yan Yan Cui; Raman Venkataramanan
Journal:  Drug Metab Dispos       Date:  2004-05       Impact factor: 3.922

9.  Intrahepatic cholestasis as a canalicular motility disorder. Evidence using cytochalasin.

Authors:  M J Phillips; C Oshio; M Miyairi; C R Smith
Journal:  Lab Invest       Date:  1983-02       Impact factor: 5.662

10.  Increased iNOS activity is essential for hepatic epithelial tight junction dysfunction in endotoxemic mice.

Authors:  Xiaonan Han; Mitchell P Fink; Takashi Uchiyama; Runkuan Yang; Russell L Delude
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-08-28       Impact factor: 4.052

View more
  32 in total

1.  Extracellular matrix scaffolding guides lumen elongation by inducing anisotropic intercellular mechanical tension.

Authors:  Qiushi Li; Yue Zhang; Perrine Pluchon; Jeffrey Robens; Keira Herr; Myriam Mercade; Jean-Paul Thiery; Hanry Yu; Virgile Viasnoff
Journal:  Nat Cell Biol       Date:  2016-02-15       Impact factor: 28.824

2.  β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.

Authors:  Michael D Thompson; Akshata Moghe; Pamela Cornuet; Rebecca Marino; Jianmin Tian; Pengcheng Wang; Xiaochao Ma; Marc Abrams; Joseph Locker; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  Hepatology       Date:  2018-01-26       Impact factor: 17.425

3.  Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.

Authors:  Hannah Jones; Laura Hargrove; Lindsey Kennedy; Fanyin Meng; Allyson Graf-Eaton; Jennifer Owens; Gianfranco Alpini; Christopher Johnson; Francesca Bernuzzi; Jennifer Demieville; Sharon DeMorrow; Pietro Invernizzi; Heather Francis
Journal:  Hepatology       Date:  2016-07-30       Impact factor: 17.425

4.  Spontaneous repopulation of β-catenin null livers with β-catenin-positive hepatocytes after chronic murine liver injury.

Authors:  Michael D Thompson; Emily D Wickline; William B Bowen; Amy Lu; Sucha Singh; Amalea Misse; Satdarshan P S Monga
Journal:  Hepatology       Date:  2011-07-21       Impact factor: 17.425

5.  Hepatocyte γ-catenin compensates for conditionally deleted β-catenin at adherens junctions.

Authors:  Emily Diane Wickline; Prince Kwaku Awuah; Jaideep Behari; Mark Ross; Donna B Stolz; Satdarshan P S Monga
Journal:  J Hepatol       Date:  2011-04-13       Impact factor: 25.083

Review 6.  Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology.

Authors:  Jacquelyn O Russell; Satdarshan P Monga
Journal:  Annu Rev Pathol       Date:  2017-11-10       Impact factor: 23.472

7.  Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury.

Authors:  Bilon Khambu; Tiangang Li; Shengmin Yan; Changshun Yu; Xiaoyun Chen; Michael Goheen; Yong Li; Jingmei Lin; Oscar W Cummings; Youngmin A Lee; Scott Friedman; Zheng Dong; Gen-Sheng Feng; Shangwei Wu; Xiao-Ming Yin
Journal:  Hepatology       Date:  2019-03-08       Impact factor: 17.425

Review 8.  The Wnt/β-catenin signaling pathway in liver biology and disease.

Authors:  Jaideep Behari
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-12       Impact factor: 3.869

Review 9.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

10.  Loss of hepatocyte β-catenin protects mice from experimental porphyria-associated liver injury.

Authors:  Harvinder Saggi; Dhiman Maitra; An Jiang; Rong Zhang; Pengcheng Wang; Pamela Cornuet; Sucha Singh; Joseph Locker; Xiaochao Ma; Harry Dailey; Marc Abrams; M Bishr Omary; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  J Hepatol       Date:  2018-10-01       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.